Tadawul
·
Healthcare
·
Pharmaceuticals
·
Last Close
$37.84
▲ +0.28%
Key Metrics
P/E Ratio
20.68
FWD: 17.81
Market Cap
$2.65B
Mid Cap
Div Yield
2.97%
Semi-annual dividend
EPS Growth
+12.67%
YoY
RSI (14)
58.47
Momentum
Beta
N/A
vs Market
52W High
$44.04
14.16% below
52W Low
$33.31
13.55% above
Volume
14.04K
Avg 36.96K
P/B
5.80
Price-to-book
ROE
28.92%
Return on equity
Free Float
38.61%
Public shares
Historical Returns
5D
+1.36%
1M
-3.14%
3M
-7.55%
6M
+8.40%
YTD
-0.21%
1Y
-11.86%
3Y
+23.40%
5Y
N/A
Financials & Valuation
TTM · Annual
| Total Revenue | $400.09M |
| Net Income | $123.66M |
| Revenue Growth (YoY) | +12.39% |
| Gross Margin | 62.54% |
| Operating Margin | 31.64% |
| Net Profit Margin | 30.91% |
| ROE | 28.92% |
| ROA · ROIC | 25.84% · 28.77% |
| P/E Ratio | 20.68 |
| Forward P/E (FY1) | 17.81 |
| PEG Ratio | 0.71 |
| P/S | 6.64 |
| P/B | 5.80 |
| P/FCF | 30.01 |
| EPS Growth | +12.67% |
| Outstanding Shares | 70.00M |
Technical Indicators
| 50-Day SMA | $39.85 |
| 200-Day SMA | $39.08 |
| RSI (14) | 58.47 |
| Beta | N/A |
| 52-Week High | $44.04 |
| 52-Week Low | $33.31 |
| Volume Today | 14.04K |
| Avg Daily Volume (30D) | 36.96K |
| Relative Volume | 0.38x |
| Volatility (10D) | 14.23 |
| Volatility (30D) | 22.39 |
| Free Float | 38.61% |